This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  83R2570 SLB-F
 
  By: Williams S.B. No. 227
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the dispensation of aesthetic pharmaceuticals by
  physicians.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 157.002(f), Occupations Code, is amended
  to read as follows:
         (f)  Subsections (b) and (c) do not authorize a physician or
  a person acting under the supervision of a physician to keep a
  pharmacy, advertised or otherwise, for the retail sale of dangerous
  drugs, other than as authorized under Sections [Section] 158.003
  and 158.004, without complying with the applicable laws relating to
  the dangerous drugs.
         SECTION 2.  Chapter 158, Occupations Code, is amended by
  adding Sections 158.004 and 158.005 to read as follows:
         Sec. 158.004.  DISPENSING OF AESTHETIC PHARMACEUTICALS. (a)  
  In this section, "aesthetic pharmaceutical" means:
               (1)  a drug listed in the aesthetic pharmaceutical
  group under Section 158.005; or
               (2)  a drug that:
                     (A)  is not a controlled substance;
                     (B)  requires a prescription for dispensation;
                     (C)  has been listed with the federal Food and
  Drug Administration; and
                     (D)  is prescribed for the enhancement of an
  individual's appearance.
         (b)  A physician licensed under this subtitle may dispense to
  that physician's patients an aesthetic pharmaceutical in excess of
  the patient's immediate needs without obtaining a license under
  Chapter 558.  The physician may charge a fee for dispensing the
  aesthetic pharmaceutical.
         (c)  Before dispensing an aesthetic pharmaceutical to a
  patient, a physician must inform the patient that the prescription
  for the aesthetic pharmaceutical may be filled at a pharmacy, if
  available at a pharmacy, or dispensed in the physician's office.
         (d)  Each state and federal labeling and recordkeeping
  requirement applicable to the aesthetic pharmaceutical must be
  followed and documented.  A record maintained under this section
  must be accessible as provided under state and federal law.
         (e)  The board, with the advice of the Texas State Board of
  Pharmacy, shall adopt rules to govern the packaging, labeling, and
  dispensation of aesthetic pharmaceuticals by a physician under this
  section and reasonable fees as necessary to implement this section.
  A fee adopted under this subsection may not exceed a fee adopted
  under Section 554.006 for authorizing a pharmacist to dispense
  pharmaceuticals.
         Sec. 158.005.  AESTHETIC PHARMACEUTICAL GROUP.  The
  aesthetic pharmaceutical group consists of:
               (1)  bimatoprost;
               (2)  hydroquinone;
               (3)  tretinoin;
               (4)  metronidazole; and
               (5)  tazarotene.
         SECTION 3.  Section 563.051(d), Occupations Code, is
  amended to read as follows:
         (d)  This section does not authorize a physician or a person
  acting under the supervision of a physician to keep a pharmacy,
  advertised or otherwise, for the retail sale of dangerous drugs,
  other than as authorized under Sections [Section] 158.003 and
  158.004, without complying with the applicable laws relating to the
  dangerous drugs.
         SECTION 4.  The Texas Medical Board shall adopt rules for the
  implementation of Section 158.004, Occupations Code, as added by
  this Act, not later than March 1, 2014.
         SECTION 5.  (a)  Except as provided by Subsection (b) of this
  section, this Act takes effect immediately if it receives a vote of
  two-thirds of all the members elected to each house, as provided by
  Section 39, Article III, Texas Constitution.  If this Act does not
  receive the vote necessary for immediate effect, this Act takes
  effect September 1, 2013.
         (b)  Section 158.004, Occupations Code, as added by this Act,
  takes effect March 1, 2014.